Molecular Profiling-based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs AZD-1775 (Primary) ; Carboplatin (Primary) ; Everolimus (Primary) ; Temozolomide (Primary) ; Trametinib (Primary) ; Veliparib (Primary)
- Indications Solid tumours
- Focus Pharmacogenomic; Therapeutic Use
- 08 Jan 2018 Status changed from recruiting to suspended.
- 07 Jun 2016 Interim results (n=60) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 03 Jun 2013 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.